214
Views
1
CrossRef citations to date
0
Altmetric
Reviews

An Introduction to the Relationship Between Lewis x and Malignancy Mainly Related to Breast Cancer and Head Neck Squamous Cell Carcinoma (HNSCC)

Pages 173-183 | Received 23 Nov 2020, Accepted 05 Dec 2021, Published online: 15 Dec 2021
 

Abstract

Lewis x functions as an adhesion molecule in glycolipids and glycoproteins since it mediates homophilic and heterophilic attachment of normal and tumoral cells. During malignancy, altered glycosylation is a frequent event; accumulating data support the expression of Lewis x in tumors although controversial results have been described including its relationship with patient survival. This report has been developed as an introduction to the relationship between Lewis x expression and breast cancer and head and neck squamous cell carcinoma (HNSCC). Results obtained in our laboratory are presented in the context of the literature.

Acknowledgments

The author is extremely grateful to Prof. Tatsuro Irimura for his expert comments and suggestions. Prof. Maria Virginia Croce is member of the Research Career of the Comisión de Investigaciones Científicas of the provincia de Buenos Aires.

Disclosure statement

The author declare that has no financial relationship that may lead to a conflict of interest in relation to the submitted manuscript.

Additional information

Funding

This study was supported by the National University of La Plata [Research grant number M198].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.